755 filings
Page 3 of 38
SD
zbbjqm bxben
20 May 22
Conflict minerals disclosure
4:06pm
PX14A6G
ni2wz6ri
13 May 22
Letter to shareholders
2:32pm
8-K
tka ocykqss
28 Apr 22
Merck Announces First-Quarter 2022 Financial Results
6:35am
8-K
z7e0f3v hp
20 Apr 22
Results of Operations and Financial Condition
6:45pm
DEFA14A
jweiei
4 Apr 22
Additional proxy soliciting materials
4:37pm
8-K
iph0h fbwl7l796
25 Mar 22
Amendments to Articles of Incorporation or Bylaws
4:14pm
8-K
gsf2gdst96r2xa
3 Feb 22
Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results
6:39am
8-K
9ghcj4n vo
10 Dec 21
Other Events
5:25pm
424B5
xc10ykphk
9 Dec 21
Prospectus supplement for primary offering
4:37pm
FWP
yomvea
8 Dec 21
Free writing prospectus
12:00am
424B5
sbcwby1v
7 Dec 21
Prospectus supplement for primary offering
8:13am
8-K
o64fd4kh2n90cv3
28 Oct 21
Merck Announces Third-Quarter 2021 Financial Results
6:40am
25-NSE
y0x rota1fz23sjo
15 Oct 21
Exchange delisting
10:14am
8-K
q9dkq4
20 Aug 21
Departure of Directors or Certain Officers
4:55pm
8-K
3nffix9q7ny m9p
29 Jul 21
Merck Announces Second-Quarter 2021 Financial Results
7:01am